Table of Contents page: Journal of Hepatology

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial Board

Published in issue: March 2013

i

The International Liver Congress™ by EASL, Amsterdam 2013

Published in issue: March 2013

ii

Liver Cancer Management: EASL Special Conference, Istanbul, June 2013

Published in issue: March 2013

iii

Bacterial Infections in Cirrhosis, EASL Monothematic Conference, Barcelona 2013

Published in issue: March 2013

iv

Translational Research in Chronic Viral Hepatitis, EASL Monothematic Conference, Lyon 2013

Published in issue: March 2013

v

EASL Sponsors 2013

Published in issue: March 2013

x

Focus

Scott L. Friedman

Published online: December 14, 2012

p407-408

Silibinin: An old drug in the high tech era of liver transplantation

Peter Ferenci,
Sandra Beinhardt

Published online: November 28, 2012

p409-411

Open Access

Hepatitis C infection and presence of advanced fibrosis: Wait or treat? Why wait? There is no time to lose, is there?

Hans Ludger Tillmann

Published online: December 14, 2012

p412-414

Open Access

Research Articles

Viral Hepatitis

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period

Zoe Mariño,
Gonzalo Crespo,
Massimo D’Amato,
...
Josep Costa,
Miquel Navasa,
Xavier Forns

Published online: October 11, 2012

p415-420

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period

Rafael Bárcena,
Ana Moreno,
Miguel Angel Rodríguez-Gandía,
...
María Luisa Mateos,
Santos del Campo
On behalf of the Hospital Ramón y Cajal Liver Transplant Group

Published online: October 15, 2012

p421-426

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

Takashi Kumada,
Hidenori Toyoda,
Toshifumi Tada,
...
Yusuke Andou,
Kenta Yamamoto,
Junko Tanaka

Published online: November 01, 2012

p427-433

The natural history of compensated HCV-related cirrhosis: A prospective long-term study

Eduardo Vilar Gomez,
Yoan Sanchez Rodriguez,
Luis Calzadilla Bertot,
...
Enrique Arus Soler,
Ali Yasells Garcia,
Luis Perez Blanco

Published online: October 29, 2012

p434-444

Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202)

Oliver Lenz,
Leen Vijgen,
Jan Martin Berke,
...
Goedele De Smedt,
Christophe Moreno,
Gaston Picchio

Published online: November 08, 2012

p445-451

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study

Thierry Poynard,
Jordi Bruix,
Eugene R. Schiff,
...
Margaret Burroughs,
Clifford A. Brass,
Janice K. Albrecht

Published online: November 15, 2012

p452-459

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland

Scott A. McDonald,
Sharon J. Hutchinson,
Norah E. Palmateer,
...
Sheila O. Cameron,
David J. Goldberg,
Avril Taylor

Published online: November 12, 2012

p460-466

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

Matthew T. Kitson,
Gregory J. Dore,
Jacob George,
...
Martin D. Weltman,
Wendy S. Cheng,
Stuart K. Roberts

Published online: November 26, 2012

p467-472

Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

Julie Bottero,
Anders Boyd,
Joel Gozlan,
...
Marc Bary,
Pierre-Marie Girard,
Karine Lacombe

Published online: November 26, 2012

p473-478

Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

Savino Bruno,
John M. Vierling,
Rafael Esteban,
...
Clifford A. Brass,
Seth Thompson,
Margaret H. Burroughs

Published online: November 26, 2012

p479-487

Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure

Graham R. Foster,
Stefan Zeuzem,
Pietro Andreone,
...
Shelley George,
Maria Beumont,
Gaston Picchio

Published online: November 26, 2012

p488-494

Cancer

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

Eiichi Ogawa,
Norihiro Furusyo,
Eiji Kajiwara,
...
Shinji Shimoda,
Jun Hayashi
The Kyushu University Liver Disease Study (KULDS) Group

Published online: October 23, 2012

p495-501

Multi-target lentivirus specific to hepatocellular carcinoma: In vitro and in vivo studies

Ye-Wei Zhang,
Jian Niu,
Xiang Lu,
...
Ji-feng Feng,
Huan-zhou Xue,
Wan Yee Lau

Published online: November 12, 2012

p502-508

The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma

Momar Diouf,
Thomas Filleron,
Jean-Claude Barbare,
...
Laetitia Dahan,
Xavier Paoletti,
Franck Bonnetain

Published online: November 23, 2012

p509-521

Molecular and Cell Biology

miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression

Jiang Li,
Mohammed Ghazwani,
Yifei Zhang,
...
Jie Fan,
Chandrashekhar R. Gandhi,
Song Li

Published online: November 22, 2012

p522-528

Cholestasis and Autoimmune Diseases

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

Christina Weiler-Normann,
Christoph Schramm,
Alexander Quaas,
...
Nadine Pannicke,
Sina Möller,
Ansgar W. Lohse

Published online: November 22, 2012

p529-534

Genetic and Metabolic Diseases

MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis

Jichao Liang,
Changzheng Liu,
Aijun Qiao,
...
Yong Chen,
Fude Fang,
Yongsheng Chang

Published online: October 29, 2012

p535-542

Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath

Froukje J. Verdam,
Jan W. Dallinga,
Ann Driessen,
...
Sander S. Rensen,
Jan Willem M. Greve,
Frederik Jan van Schooten

Published online: November 08, 2012

p543-548

Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

Aloysious Aravinthan,
Cinzia Scarpini,
Phaedra Tachtatzis,
...
Michael Allison,
Nick Coleman,
Graeme Alexander

Published online: November 09, 2012

p549-556

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China

Huating Li,
Kun Dong,
Qichen Fang,
...
Kunsan Xiang,
Aimin Xu,
Weiping Jia

Published online: November 08, 2012

p557-563

Innate immunity and HCV

Markus H. Heim

Published online: October 11, 2012

p564-574

Open Access

The dynamic biliary epithelia: Molecules, pathways, and disease

Steven P. O’Hara,
James H. Tabibian,
Patrick L. Splinter,
Nicholas F. LaRusso

Published online: October 18, 2012

p575-582

Open Access

Perspectives and challenges of interferon-free therapy for chronic hepatitis C

Christian M. Lange,
Stefan Zeuzem

Published online: October 25, 2012

p583-592

Open Access

The burden of liver disease in Europe: A review of available epidemiological data

Martin Blachier,
Henri Leleu,
Markus Peck-Radosavljevic,
Dominique-Charles Valla,
Françoise Roudot-Thoraval

Published in issue: March 2013

p593-608

Open Access

Frontiers in Liver Transplantation

Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate

Matteo Cescon,
Alessandro Cucchetti,
Matteo Ravaioli,
Antonio Daniele Pinna

Published online: October 08, 2012

p609-618

Open Access

International Hepatology

AMPK regulates macrophage polarization in adipose tissue inflammation and NASH

Shih-Yen Weng,
Detlef Schuppan

Published online: October 08, 2012

p619-621

Open Access

Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt/β-catenin

Andreas Teufel,
Jens U. Marquardt,
Peter R. Galle

Published online: October 11, 2012

p622-624

Open Access

Clinical Application of Basic Science

Induced pluripotent stem cells: From Nobel Prizes to clinical applications

S. Tamir Rashid,
Graeme J.M. Alexander

Published online: November 05, 2012

p625-629

Open Access

A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production)

Helena Moreira Silva,
Guilhermina Reis,
Margarida Guedes,
...
Deirdre Kelly,
Andrew R. Gennery,
Ermelinda Santos Silva

Published online: October 26, 2012

p630-633

Open Access

Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation

Susan Leanne Samson,
Mandeep Bajaj

Published online: November 15, 2012

p634-635

Open Access

Reply to: “Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation”

Sigal Fishman,
Isabel Zvibel

Published online: November 15, 2012

p635-636

Open Access

Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?

Beatrice Conti,
Antonella Minutolo,
Mario Arciello,

Clara Balsano

Published online: November 28, 2012

p636-637

Open Access

Reply to: “Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?”

Damien Grégoire,
Leila Akkari,
Christophe Carenco,
Urszula Hibner

Published online: November 29, 2012

p637-638

Open Access

Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open

Thierry Thevenot,
Elisabeth Monnet,
Vincent Di Martino

Published online: December 07, 2012

p638-639

Open Access

Reply to: “Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open”

Mónica Guevara,
Vicente Arroyo,
Pere Ginès

Published online: December 07, 2012

p640

Open Access

EASL iLiver Android

Published in issue: March 2013

IBC

Course 21: General Hepatology, EASL Clinical School of Hepatology, Bern 2013

Published in issue: March 2013

OBC

March 2013

Focus

Editorials

Research Articles

Viral Hepatitis

Cancer

Molecular and Cell Biology

Cholestasis and Autoimmune Diseases

Genetic and Metabolic Diseases

Reviews

Special Review

Special Sections

Frontiers in Liver Transplantation

International Hepatology

Clinical Application of Basic Science

Case Report

Letters to the Editor

Persistent activation of Hedgehog or Wnt/β-catenin pathways is not involved in EMT mediated by HCV NS5A protein